Abstract: Drug studies are powerful models to investigate the neuropharmacological mechanisms underlying temporal processing in humans. This study administered dexamphetamine to 24 healthy volunteers to investigate time perception at different time scales, along with contributions from working memory. Healthy volunteers were administered 0.45 mg/kg dexamphetamine or placebo in a doubleblind, crossover, placebo-controlled design. Time perception was assessed using three experimental tasks: a time-discrimination task, which asked participants to determine whether a comparison interval (1200 AE 0, 50, 100, 150, 200 ms) was shorter or longer than a standard interval (1200 ms); a retrospective time estimation task, which required participants to verbally estimate time intervals (10, 30, 60, 90 and 120 s) retrospectively; and a prospective time-production task, where participants were required to prospectively monitor the passing of time (10, 30, 60, 90 and 120 s). Working memory was assessed with the backwards digit span. On the discrimination task, there was a change in the proportion of long-to-short responses and reaction times in the dexamphetamine condition (but no association with working memory), consistent with an increase in the speed of an internal pacemaker, and an overestimation of durations in the timing of shorter intervals. There was an interaction between dexamphetamine, working memory, and performance on the estimation and production tasks, whereby increasing digit span scores were associated with decreasing interval estimates and increased produced intervals in the placebo condition, but were associated with increased interval estimates and decreased produced intervals after dexamphetamine administration. These findings indicate that the dexamphetamine-induced increase in the speed of the internal pacemaker was modulated by the basal working memory capacity of each participant. These findings in healthy humans have important implications for the role of dopamine, and its contributions to timing deficits, in models of psychiatric disorders.
studies have been consistent in showing fundamental dysfunctions in time perception in multiple psychiatric and psychological disorders, including schizophrenia (Giersch, Lalanne, & Isope, 2016; Giersch et al., 2015; Martin et al., 2014 ), Parkinson's disease (Artieda, Pastor, Lacruz, & Obeso, 1992; Pastor, Artieda, Jahanshahi, & Obeso, 1992; Shea-Brown, Rinzel, Rakitin, & Malapani, 2006) , attention deficit hyperactivity disorder (Kerns, McInerney, & Wilde, 2001; Toplak, Dockstader, & Tannock, 2006) , and major depressive disorder (Sévigny, Everett, & Grondin, 2003; Thönes & Oberfeld, 2015) . One goal of neuropharmacological research is to identify the underlying pathological changes that result in such changes to time perception.
Scalar timing theory and time perception
The predominant model of time perception, scalar timing theory (Gibbon, 1977 (Gibbon, , 1991 Gibbon & Church, 1982) , proposes the existence of several components that contribute to time perception in both humans and non-human animals. These include a pacemaker that produces units of time in pulses, and an accumulator that stores these time pulses (together referred to as the "clock stage"). These processes operate to accumulate temporal units over a given interval. The subsequent stages prepare this information for further cognitive processing: the memory stage stores information from the accumulator, while the comparator subsequently compares the duration from the accumulator with previous durations to identify intervals of different durations. In addition, these stages are controlled by an attention-gated switch that can turn on and off the accumulation of time units according to whether the individual is attending to the relevant interval (Gibbon, Church, & Meck, 1984; Meck & Benson, 2002; Taatgen, van Rijn, & Anderson, 2007) .
It is broadly acknowledged that the processing of intervals between milliseconds and minutes can be divided into several interval ranges, each with dedicated underlying neural networks. One such proposal is that time perception can be divided into at least three main ranges: less than 500 ms, hundreds of milliseconds to 2-3 s, and multiple seconds to minutes (Gibbon, Malapani, Dale, & Gallistel, 1997; Grondin, 2010; Merchant, Harrington, & Meck, 2013; Wittmann, 1999; Wittmann et al., 2007) . Time perception for sub-500-ms intervals is broadly automatic, unconscious, and closely linked to multisensory integration and perception of separate sensory stimuli (Lewis & Miall, 2003a , 2003b Rammsayer & Lima, 1991) . Processing of intervals in the range of hundreds of milliseconds to seconds (hundreds-to-thousands of milliseconds) is associated with the selection, execution, and coordination of specific action units, and to the subjective experience of "nowness," the so-called psychological present (Fraisse, 1984; Ivry & Spencer, 2004; Merchant et al., 2013; Wittmann, 1999) . Within this time range, stimuli are processed and perceived as a perceptual whole. Intervals above this range, lasting from seconds-to-minutes, need to be linked by some form of memory process and are thus estimated and not perceived (Wittmann, 1999) . In contrast to intervals less than 500 ms, temporal processing of intervals in the ranges of hundreds-to-thousands of milliseconds and seconds-tominutes requires the recruitment of cognitive processes, such as working memory and sustained attention (Fortin, 1999; Fortin & Breton, 1995; Fortin, Rousseau, Bourque, & Kirouac, 1993; Rammsayer & Lima, 1991; Rammsayer & Vogel, 1992) . Specifically, the accumulator stage is proposed to be tightly linked with working memory, such that the number of pulses for the current interval, produced by the internal pacemaker, are stored in working memory until an external signal indicates that the current interval is over (Gibbon et al., 1984; Lewis & Miall, 2006) . Accordingly, it is possible to isolate changes to temporal processing that are specific to alterations in the speed of the internal pacemaker (Rammsayer, 1997 (Rammsayer, , 1999 or of the ability of the accumulator to maintain the time units stored within it (Elvevåg, Brown, McCormack, Vousden, & Goldberg, 2004; Roy, Grondin, & Roy, 2012) . Both an increase in the rate of the internal pacemaker and an improvement in the ability to maintain time units in working memory result in a faster accumulation of temporal units, meaning participants tend to underproduce, and overestimate, intervals. Conversely, a reduction in the pace of the internal pacemaker or a reduction in the retention of time units in working memory results in a slower accumulation of temporal units, and an overproduction and underestimation of intervals. Time perception of seconds-to-minutes intervals is also dependent upon the processing of shorter intervals, given the involvement of a common pacemaker system (Gibbon et al., 1997; Lewis & Miall, 2009; Rammsayer & Brandler, 2004) . The current study focuses on the interval ranges of hundreds-to-thousands of milliseconds and seconds-to-minutes.
A further distinction can also be made between accuracy and precision in temporal processing. Accuracy refers to the deviation of estimates from the actual interval being assessed, while precision refers to the variability of those judgments (often assessed through measures such as the Weber fraction; Agostino & Cheng, 2016; Grondin, 2010; Thoenes & Oberfeld, 2017) . This distinction is important as accuracy and precision may be impacted independently depending on the exact nature of any change/s in the stages of temporal processing. For example, a consistent increase in the speed of the internal pacemaker will cause a shift in the accuracy (due to increased accumulation of temporal units) but will also increase precision due to the increase of temporal resolution (i.e., more temporal units in a given interval; Rammsayer, 1990) . Conversely, a consistent reduction in clock speed will cause a shift in accuracy in the opposite direction to an increased clock speed, while also reducing precision. Disorders of attention, such as in attention deficit hyperactivity disorder, may cause the attention-gated switch to "flicker" on and off, resulting in increased variability in accumulation of time units, and a reduction in precision, without necessarily impacting accuracy (Meck & Benson, 2002) . Thus, investigations of timing and time perception can determine whether accuracy, precision, or both, are impacted by alterations in the various stages of temporal processing.
Background on the dopaminergic regulation of time perception
A central role for dopamine in time perception has been demonstrated through: lesion studies in animals (Meck, 2006; Olton, Meck, & Church, 1987) and humans (Aparicio, Diedrichsen, & Ivry, 2005; Shin, Aparicio, & Ivry, 2005) ; findings in animal models after administration of dopaminergic agonists (e.g., Cheng, MacDonald, & Meck, 2006; MacDonald & Meck, 2005; Matell, Bateson, & Meck, 2006; Saulsgiver, McClure, & Wynne, 2006) and antagonists (Buhusi & Meck, 2002; Cheng & Liao, 2007; Drew, Fairhurst, Malapani, Horvitz, & Balsam, 2003; ; and observations of people with Parkinson's disease, both with and without L-DOPA treatment Jones, Malone, Dirnberger, Edwards, & Jahanshahi, 2008; Pastor et al., 1992) .
Taken together, this research indicates that dopamine transmission works to regulate the speed of the internal pacemaker, with high levels of dopamine resulting in an increase in this speed and an increase in the number of temporal units accumulated in an interval. Conversely, low levels of dopamine transmission result in a reduction of the speed of the pacemaker and a reduction in the number of temporal units accumulated in an interval.
According to one model (Matell & Meck, 2004; Meck & Benson, 2002; Meck, Penney, & Pouthas, 2008) , the clock stage of temporal processing corresponds to a corticostriatal network that consists of different neuron populations in the frontal cortex that oscillate at different frequencies. Medium spiny neurons in the dorsal striatum receive input from these neurons and detect particular patterns of cortical activation that correspond to specific intervals. Dopamine appears to be important in the regulation of both the synchronized firing of the cortical neurons (Matell & Meck, 2004; Meck & Benson, 2002; Meck et al., 2008) and regulation of the medium spiny neurons in the striatum (Meck, 1986; Surmeier, Ding, Day, Wang, & Shen, 2007) .
Investigations of dopaminergic manipulations in healthy volunteers
In contrast to the vast literature in animal models, little work has been done to examine the effects of increased dopamine transmission in healthy humans. Studies involving administration of D 2 -receptor antagonists, primarily haloperidol, to healthy volunteers have consistently found that the ability to discriminate between intervals of different lengths, for intervals in both the hundreds-to-thousands of milliseconds and seconds-tominutes ranges, is impaired and there are changes in time perception consistent with decreased clock speed (Lake & Meck, 2013; Lustig & Meck, 2005; Rammsayer, 1993 Rammsayer, , 1997 Rammsayer, , 1999 Rammsayer & Vogel, 1992) . A further study investigated the impact of reduced dopamine transmission, achieved via depletion of endogenous dopamine production, on the ability to discriminate between intervals of 540, 1080, and 1620 ms (Coull, Hwang, Leyton, & Dagher, 2012) . It was found that reduced dopamine transmission resulted in an increased error rate on this task. However, as only the percentage of correct responses across all intervals was analyzed, and no measure of perceived length of the intervals was reported, it is not clear if the impaired performance is due to an increase or decrease in the rate of the internal pacemaker in this study. These results are, however, consistent with a decrease in precision in temporal judgments.
A common compound used to increase dopamine transmission is dexamphetamine. Dexamphetamine is the dextrorotary stereoisomer of the amphetamine molecule and an indirect dopamine agonist that functions by displacing dopamine from presynaptic vesicles as well as reversing the direction of the membrane-bound dopamine transporter (DAT), resulting in increased synaptic levels of dopamine (Hegadoren et al., 1994; Philips, Robson, & Boulton, 1982; Sulzer et al., 1995) . One study found that variability, but not accuracy, in time perception of seconds-to-minutes intervals was affected after administration of 15 mg dexamphetamine to healthy volunteers (Weiner & Ross, 1962) . A further study administered 0.1 mg of the dopamine receptor agonist, pergolide, and found that healthy volunteers were better able to discriminate between intervals of 50 AE 15 ms compared to placebo, and a decrease in the Weber fraction, indicative of an increase in precision, for judgments of these brief intervals. No effects of pergolide on temporal discrimination for intervals of 1000 AE 500 ms were found (Rammsayer, 2009) . Lake and Meck (2013) demonstrated that administration of 20 mg dexamphetamine resulted in a leftward shift in responses during a peak interval procedure (of 7-s and 17-s intervals), consistent with an increase in the speed of the internal pacemaker. This effect, however, was only present in a subgroup of participants who showed significantly more baseline lapses of attention and reported significantly less enjoyment of the subjective effects of dexamphetamine. Conversely, participants who displayed low levels of attentional lapses and reported high levels of liking dexamphetamine displayed the opposite effect (a rightward-shift in the peak). The authors interpreted this effect as a result of the euphoric effects of dexamphetamine distracting participants from the peak interval task, drawing attention and other cognitive resources away from the temporal-processing task. In accordance with scalar timing theory, this would prevent the attention-gated switch from closing and time units from accumulating, requiring longer actual intervals for these participants to perceive the target intervals.
From these studies, it is difficult to determine what the effects of increased dopamine transmission on time perception in healthy humans are and what stage of the scalar timing model is impacted.
Inverted U-curve of performance and dopamine
It has been hypothesized that behaviors regulated by dopamine require a narrow range of dopamine transmission for optimal performance, and that changes in this level in either direction may be detrimental to performance (Arnsten, 1998) , the so-called inverted U-curve of performance (Baldi & Bucherelli, 2005) . According to this hypothesis, every individual has a unique basal level of dopamine transmission that is closely linked to baseline cognitive function, particularly attention and working memory. More precisely, people who perform poorly on working memory tasks in baseline conditions demonstrate improved working memory after administration of dopamine agonists. Conversely, people who perform optimally on working memory tasks in baseline conditions demonstrate diminished performance after administration of dopamine agonists (Cools & D'Esposito, 2011; Goldman-Rakic, 1997; Goto, Otani, & Grace, 2007; Mattay et al., 2000; Vijayraghavan, Wang, Birnbaum, Williams, & Arnsten, 2007) . Given the recruitment of working memory during the time perception of seconds-to-minutes intervals (see above) and previous proposals that time perception may be influenced by dopaminergic regulation of attention and working memory (Rammsayer, 1999) , we hypothesized that the effects of dexamphetamine on the clock stage of temporal processing may be mediated by its effects on working memory and the accumulator stage of temporal processing.
Aims and hypotheses
The broad objective of the current study was to investigate the role of increased dopamine transmission induced by dexamphetamine on different aspects of time perception in healthy volunteers, and its interaction with working memory. We utilized a double-blind, placebo-controlled, crossover design in which participants were administered 0.45 mg/kg dexamphetamine sulfate or placebo. The time-perception tasks included (1) a timediscrimination (TD) task in which standard and comparison intervals were presented and participants were asked to indicate if the comparison interval was shorter or longer in duration than the standard interval (in the hundreds-tothousands of milliseconds range); (2) a retrospective time estimation (RTE) task in which participants were required to estimate the duration of a time interval (seconds-tominutes range); and (3) a prospective time production (PTP) task in which participants were asked to indicate when a pre-determined time interval had elapsed (secondsto-minutes range).
We hypothesized that dexamphetamine administration would induce changes in time perception consistent with an increase in the speed of the internal pacemaker, in other words, an increase in the number of time units accumulated in an interval, on hundreds-to-thousands of milliseconds intervals. Specifically, we hypothesized that, (1) compared to placebo, participants administered dexamphetamine would report more comparison intervals to be "longer" in the TD task (as reflected in a leftwards shift of the point of subjective equality). The increase in temporal resolution due to the increase in clock speed would also result in increased precision and a corresponding lower Weber fraction in the dexamphetamine condition. In the RTE and PTP tasks, by contrast, we hypothesized that (2) the effects of dexamphetamine on time perception would be mediated by working memory (as assessed by the backwards digit span task). Specifically, that increased working memory capacity (and hence better retention of temporal units) would be associated with shorter produced intervals and overestimation of elapsed intervals. We hypothesized that (3) dexamphetamine would disrupt this relationship, as it improved the working memory capacity of those participants with low placebo digit span scores and impair the working memory capacity of those with optimal placebo digit span scores. Finally, we hypothesized that (4) the Weber fraction from the RTE and PTP tasks would be decreased after dexamphetamine administration.
Materials and methods
Participants Twenty-four participants (see Table 1 for demographic characteristics of the sample) were recruited via advertisement at the University of Western Australia. Exclusionary criteria-as assessed in pre-screening questionnaires and interviews-included (1) current diagnosis or treatment for psychiatric disorder/s, (2) current diagnosis or treatment for neurological disorder/s or known seizure risk, (3) respiratory or cardiovascular disorders, (4) kinetic disorders, (5) hepatic insufficiency, (6) renal insufficiency, (7) significant risk of suicide, (8) a family history of schizophrenia in first-degree relatives, (9) glaucoma, (10) hypertension, (11) hyperthyroidism, (12) known hypersensitivity to dexamphetamine or sympathomimetic amines, (13) current or past history of treatment for a substance abuse disorder, (14) prescription medication (other than oral contraceptives), (15) pregnancy or currently breastfeeding, and (16) use of any over-thecounter medication in the 48 hr before each testing session. Participants must have also reported abstinence from alcohol and recreational substances for 24 hr prior to each testing session. All participants received medical and psychiatric screening prior to participation in the study and provided written consent. Participants were reimbursed for their participation in the study. The study protocol was approved by the ethics committees of the University of Western Australia and the North Metropolitan Area Mental Health Service. The study was registered with the Australian and New Zealand Clinical Trials Registry under the identification number ACTRN12608000610336.
Experimental design
The experiment was a fully balanced, within-subject, double-blind, placebo-controlled, cross-over design. Each participant was pseudo-randomly assigned a drug-order (counter-balanced across all subjects). Participants each attended two sessions separated by at least 6 days. In one session, participants were given a single dose of dexamphetamine sulfate (Sigma Pharmaceuticals Pty Ltd., Victoria, Australia) at 0.45 mg/kg (to the nearest 2.5 mg) in oral capsule form. This research group has demonstrated that administration of this dose of dexamphetamine induces changes in multiple behavioral (Albrecht et al., 2011; Chitty et al., 2014) and physiological markers (Albrecht, Price, Lee, Iyyalol, & Martin-Iverson, 2013; Albrecht et al., 2016) . The mean weight and dose of participants are given in Table 1 . In the other session, participants were given identical capsules filled with the equivalent weight in glucose powder as a placebo. Blood pressure and heart rate were measured using an automatic sphygmomanometer (Microlife, Switzerland) just prior to, and 75, 130, 180, and 270 min after administration; the effects of dexamphetamine on the physiological measures can be seen in Table 2 . The timing of the testing session and the time the various tests were performed after administration of placebo/dexamphetamine can be seen in Table 3 .
TD task
In the TD task, adapted from Rao, Mayer, and Harrington (2001) , participants first heard two tones separated by a standard interval of 1200 ms. These tones were followed 1000 ms later by two further tones separated by a comparison interval (1200 AE 0, 50, 100, 150, 200 ms). Participants were required to determine whether the comparison interval (between the third and fourth tone) was shorter or longer than the standard interval (between the first and second tone). One block of four practice trials and six blocks of nine trials (one of each comparison interval) were presented. The experimental trials started when participants could explain the task requirements back to the experimenter and show correct performance on the practice trials. All tones were 50 ms in duration and 700-Hz frequency and were presented binaurally through a pair of stereo headphones (Sennheiser HD25-1). Stimuli were presented and responses recorded with LabVIEW (National Instruments, version 8.2). The dependent variables of interest were the proportion of long-to-short responses and the response time (ms). Although the interval differences ranged between 0 and 200 ms, it was the encoding of the standard interval (1200 ms) by the internal clock that would most likely be affected by the administration of dexamphetamine and thus judgments required temporal resolution on the order of hundreds-to-thousands of milliseconds. The just-noticeable difference (calculated as the comparison interval that produced a proportion of 75% of long-to-short responses minus the comparison interval that produced a proportion 25% of long-to-short responses, divided by two) was produced for each individual and drug condition using the curve fits from the logistic regression mixed model (see Statistical Analysis section below). The Weber fraction was then calculated by dividing the JND by the standard interval (1200 ms).
RTE task
In this task (adapted from Mimura, Kinsbourne, & O'Connor, 2000) , participants retrospectively verbally estimated set intervals of 10, 30, 60, 90, or 120 s. Each interval was presented four times in a pseudorandom order (time was kept by the experimenter). Responses were recorded manually. To distract participants and prevent counting strategies, participants completed a secondary task involving rating the pleasantness of pictures (see the picture-rating task below). The Weber fraction was calculated for each participant, drug condition, and interval by dividing the standard deviation of the interval estimates by the interval. 0  165  270  275  295  305  Event  T1  PILL INGESTION  T2  T3  T4  T5  T6 Note. T1 = information sheet and consent form, psychological and physical examination by psychiatrist, weight taken (only occurs on the first session); T2 = verbal time estimation task; T3 = backwards digit span; T4 = time-discrimination task; T5 = time-production task; T6 = formal assessment of adverse signs and symptoms possibly caused by dexamphetamine (if no extreme signs or symptoms were shown/experienced, the participant was taken home).
PTP task
In this task (adapted from Mimura et al., 2000) , the interviewer instructed the participant to indicate when a predetermined time interval was over by pressing a spacebar on a computer. Participants were required to produce intervals of 10, 30, 60, 90, or 120 s, each of which were presented four times in a pseudorandom order. The produced interval was recorded by the computer. To distract participants from counting, random numbers were displayed on the screen, which the participants were instructed to say out loud. The task was presented using LabVIEW (National Instruments, version 8.2). The Weber fraction was calculated for each participant, drug condition, and interval by dividing the standard deviation of the produced intervals by the interval.
Backwards digit span
Participants also completed the backwards digit span task (Lezak, Howieson, Loring, Hannay, & Fischer, 1995) in both testing sessions, as a measure of working memory. For this task, the examiner verbally presented a string of digits at a rate of one per second. The participant then repeated the digits back to the examiner in reverse order. The string of digits increased by one until the participant failed to correctly repeat the order on two consecutive strings of the same length. The mean score AE SE was 7.04 AE 0.53 (range 3-12) in the placebo condition and 7.46 AE 0.55 (range 4-12) in the dexamphetamine condition; a paired t test demonstrated that the BDS scores were not significantly different between drug conditions, t(23) = -1.21, p = .24. In order to determine if the effects of dexamphetamine were mediated by the baseline working memory capacity of participants, the placebo BDS score was used in subsequent analyses.
Picture-rating task As described in the introduction, dexamphetamine-induced euphoria may mask the effects of increased dopaminergic transmission on the internal clock (Lake & Meck, 2013) . To determine if a similar effect occurred in the current study, participants also completed a picture-rating task during the RTE. Visual stimuli consisted of pictures from the unpleasant, neutral, nonsexual pleasant, and sexual pleasant categories of the International Affective Picture System (Lang, Bradley, & Cuthbert, 2008) . Pictures were presented sequentially, with a matched number of pictures from each category to minimize the effect of emotional processing on the RTE task. Pictures from each category were chosen randomly; it was possible for pictures to be displayed more than once within a session. However, only the rating of the first presentation of each picture was used in the analysis. The set of pictures displayed in the first session was then used for the subsequent session. All pictures were rated on a 9-point Likert scale. Participants were instructed that a rating of 0 meant the picture made them feel unhappy, annoyed, unsatisfied, melancholic, shocked, despairing, or bored; a rating of 4-5 meant the picture made them feel felt neutral, neither happy nor sad; a rating of 9 meant the picture made them feel happy, pleased, satisfied, contented or hopeful; and a rating of intermediate values was possible. Participants were able to view each picture for as long as they desired. When they were ready to rate the picture, they pressed the spacebar and then entered the appropriate number on the keyboard. The task was presented, and responses recorded, using LabVIEW.
Results

Statistical analyses
All analyses were conducted using R (version 3.5.1; R Core Team, 2017). The package "nlme" was used to generate the logistic regression non-linear model for the response proportion data from the TD task (version 3.1-137; Pinheiro, Bates, DebRoy, Sarkar, & R Development Core Team, 2013). The packages "lme4" (Bates, Mächler, Bolker, & Walker, 2015) and "lmerTest" (version 3.0.1; Kuznetsova, Brockhoff, & Christensen, 2017) were used for the mixed-effects models for the response time data from the time-discrimination task, the retrospective time estimation task, the prospective time-production tasks, and the Weber fractions from each task. The random effects structure of each model was chosen through assessment of alternative models with the Akaike Information Criteria and chi-square comparison. Figure production was completed using the packages "effects" (version 4.0.3; Fox, 2003; Fox & Hong, 2009 ) and "ggplot2" (version 3.0.1; Wickham, 2009 ). The fixed effects and random effects terms for each model for each of the tasks are given below. The α was set to .05.
TD task results
A three-parameter logistic regression mixed model was fitted to the proportion of long-to-short responses from the time-discrimination task. The three parameters were the asymptote, point of subjective equality (PSE; the point at which participants reported the comparison interval to be longer than the standard interval on 50% of trials), and the scale parameter. The main outcome measure was the PSE. Accordingly, drug and BDS were included as fixed effects on the PSE. Since there were no significant main effects or interactions involving BDS scores, all related fixed effects were subsequently removed from the final model. The random effects term allowed for random intercepts for participants, with drug nested within participants.
The results of this model can be seen in Table 4A . There was a significant main effect of drug on the PSE; the point at which participants began to report the comparison interval to be longer than the standard interval on more than 50% of trials occurred at a shorter comparison interval in the dexamphetamine condition than in the placebo condition. That is, participants were more likely to report the comparison interval to be longer for shorter comparison intervals after dexamphetamine administration (see Figure 1A) .
Inspection of the response time means suggested the presence of a quadratic curve for the data, with a plateau effect for 1350-ms and 1400-ms intervals. Correspondingly, a second-order polynomial non-linear mixed model was fitted with response time as the dependent variable and drug (placebo or dexamphetamine), placebo BDS score, and interval (1000, 1050, 1100, 1150, 1200, 1250, 1300 ms) as fixed effects. The random error term allowed for random intercepts for participants with drug nested within participants. There was no significant effect of BDS on any term and all terms involving the BDS were removed from the final model. The estimates of the final model can be seen in Table 4B .
The first major finding regarding the response time was that the vertex of the response curve (corresponding to the maximum response times and, hence, the subjectively most difficult trials) was also shifted to the left, in accordance with the leftwards-shift of the PSE (see Figure 1B) . A significant main effect of drug indicated that dexamphetamine administration decreased overall response time. However, significant drug by interval and drug by interval 2 interactions revealed that the effect of dexamphetamine on response time was not consistent across intervals. As can be seen in Figure 1B , the overall effect of these two interactions was that the curve for response times after dexamphetamine administration was less steep than the response time curve in the placebo condition. In other words, after dexamphetamine administration, participants responded more quickly on trials in the middle intervals (1100-1200 ms), but there was little to no effect on response times for the very short intervals (1000-1100 ms) and the very long intervals (1300 ms). A linear mixed model was fitted with the Weber fraction derived from the time-discrimination task as the dependent variable, and placebo BDS score and drug (placebo or dexamphetamine) as fixed effects. The random error term allowed for uncorrelated random intercepts for participants and random slopes for participants for the BDS. The estimates of the final model can be seen in Table 4C . The model revealed no significant main effect of BDS, no main effect of drug, and no significant interaction. Accordingly, the precision of temporal processing on the TD task was not affected by administration of dexamphetamine or by the baseline working memory capacity of the participant.
RTE task results
A linear mixed-effects model was fitted to the data with estimated intervals as the dependent variable and placebo BDS score, drug (placebo or dexamphetamine), and interval (10, 30, 60, 90, 120 s) as fixed effects. The random error term allowed for random intercepts for participants with drug nested within participants. The parameter estimates of the model are in Table 4D . Other than a significant main effect of target, two significant two-way interactions of BDS by interval and interval by drug were found. The BDS by interval interaction indicated that, in the placebo condition, the rate at which estimated intervals increased with increasing interval lengths decreased with increasing BDS scores, that is, the higher the BDS score and hence the greater the working memory capacity, the lower the estimated interval, particularly for longer intervals. The significant drug by interval interaction demonstrated that there was a reduction in the steepness of the slope of the perceived interval in the dexamphetamine condition, compared to the placebo condition and at a BDS score of zero. This is indicative of an underestimation of intervals, particularly for longer intervals, in the dexamphetamine condition by people with a low placebo BDS score. The three-way interaction of BDS, drug, and interval demonstrated that, in the dexamphetamine condition, increasing BDS scores were associated with an increase in the steepness of the slope of the perceived interval, such that participants with a high placebo BDS score overestimated intervals and this effect was more pronounced with increasing interval length. This relationship between the variables can be seen in Figure 2 . A linear mixed model was fitted with the Weber fraction as the dependent variable, and placebo BDS score, drug (placebo or dexamphetamine), and interval (10, 30, 60, 90 and 120 s) as fixed effects. The random error term allowed for uncorrelated random intercepts for participants (with drug nested within participants) and random slopes for participants for intervals. The estimates of the final model can be seen in Table 4E . The model revealed no significant main effect of BDS, no main effect of drug, no main effect of interval, and no significant interactions. These results indicate that the precision of temporal processing on the RTE task, as assessed by the Weber fraction, was not affected by administration of dexamphetamine or by the baseline working memory capacity of the participant. Importantly, the absence of a main effect of interval indicated that the Weber fraction was constant across intervals in accordance with scalar timing theory.
PTP task results
A linear mixed-effects model was fitted to the data with produced intervals as the dependent variable and drug (placebo or dexamphetamine), BDS score, and target (10, 30, 60, 90 and 120 s) as fixed effects. The random error term allowed for random intercepts for participants with drug nested within participants. The parameter estimates of the model are presented in Table 4F . As with the RTE, the model of the PTP revealed two significant two-way Note. LL = 95% confidence interval lower limit; UL = 95% confidence interval upper limit; Dex = dexamphetamine; PSE = point of subjective equality; BDS = backwards digit span; Cat = category. a Parameter estimation performed using the maximum likelihood estimation method and actual degrees of freedom. b Parameter estimation performed using the restricted maximum likelihood estimation method and Satterthwaite's approximation for degrees of freedom. Confidence intervals were calculated using the likelihood profile method and with the reference level for drug set to placebo for all models. interactions of BDS by interval and interval by drug. The BDS by interval interaction indicated that, in the placebo condition, the rate at which produced intervals increased with increasing interval lengths increased with increasing BDS scores, that is, the higher the BDS score and hence the greater the working memory capacity, the higher the produced interval, particularly for longer intervals. The significant drug by interval interaction demonstrated that there was a significant increase in the steepness of the slope of the perceived interval in the dexamphetamine condition, compared to the placebo condition and at a BDS score of zero. This is indicative of an overproduction of intervals in the dexamphetamine condition, most prominently seen at longer intervals, by people with a low placebo BDS score. The three-way interaction of BDS, drug, and interval demonstrated that, in the dexamphetamine condition, increasing BDS scores were associated with a reduction in the steepness of the slope of the perceived interval, such that participants with a high placebo BDS score underproduced intervals and this effect was more pronounced with increasing interval length. The three-way interaction between BDS, drug, and interval can be seen in Figure 3 . A linear mixed model was fitted with the Weber fraction as the dependent variable, and placebo BDS score, drug (placebo or dexamphetamine), and interval (10, 30, 60, 90 and 120 s) as fixed effects. The random error term allowed for uncorrelated random intercepts for participants (with drug nested within participants) and random slopes for participants for intervals. The estimates of the final model can be seen in Table 4G . The model revealed no significant main effect of BDS, no main effect of drug, no main effect of interval, and no significant interactions. These results indicate that the precision of temporal processing on the PTP task, as assessed by the Weber fraction, did not differ between placebo and dexamphetamine conditions, and did not differ according to the performance on the BDS in the placebo condition. As with the RTE task, the absence of a main effect of interval on the PTP task indicated that the Weber fraction was constant across intervals.
Effect of dexamphetamine on working memory
Given that increasing BDS scores in the placebo condition were associated with (1) a decrease in retrospective estimations of intervals (RTE) and (2) an increase in prospective production of intervals (on PTP), (3) this effect was reversed after dexamphetamine administration, and (4) our a priori hypothesis that performance on the RTE and PTP tasks would be mediated by baseline working memory performance, further examination of the effect of dexamphetamine on the BDS was conducted.
Participants were split into two groups: low placebo BDS scores (<7, n = 11) and high placebo BDS scores (≥7, n = 13). A linear mixed-effects model was fitted to the data with BDS score as the dependent variable and drug (placebo or dexamphetamine) and placebo BDS score (low or high) as fixed effects. The random error term allowed for random intercepts for participants. The parameter estimates of the model are in Table 4H . As expected, there was a main effect of placebo BDS score, along with a main effect of drug, indicating an increase in BDS score in the dexamphetamine condition. There was also a significant interaction between placebo BDS score and drug. This interaction demonstrated that people with high BDS scores in the placebo condition, and hence higher working memory capacity, did not demonstrate an increase in BDS scores after dexamphetamine administration. Conversely, those participants with low BDS scores in the placebo condition, and hence lower working memory capacity, demonstrated an increase in BDS scores after dexamphetamine administration.
Picture-rating task A linear mixed-effects model was fitted to the data with picture rating as the dependent variable and drug (placebo or dexamphetamine) and picture category (neutral, unpleasant, pleasant, sexual) as fixed effects. The random error term allowed for random intercepts for participants with drug nested within participants and random intercepts for individual pictures. The parameter estimates of the model are presented in Table 4I . The mean AE SEM of each condition is as follows: Placebo -Neutral = 4.10 AE 0.27, Dexamphetamine -Neutral = 4.37 AE 0.30, Placebo -Unpleasant = 2.16 AE 0.13, Dexamphetamine -Unpleasant = 2.06 AE 0.13, Placebo -Pleasant = 5.97 AE 0.10, Dexamphetamine -Pleasant = 6.19 AE 0.10, Placebo -Sexual = 5.99 AE 0.10, and Dexamphetamine -Sexual = 6.23 AE 0.10. As can be seen from the results of the linear mixed model, there were no main effects of dexamphetamine administration on the rating of the pleasantness of pictures, nor an interaction of dexamphetamine administration and picture category. In the absence of any effects of dexamphetamine, no further analysis involving the picture ratings was undertaken.
Discussion
The aim of the current study was to investigate the role of increased dopamine transmission on the time perception of intervals in healthy volunteers using a TD task (in the range of hundreds-to-thousands of milliseconds), a RTE task, and a PTP task (both in the seconds-to-minutes range) after administration of 0.45 mg/kg dexamphetamine or placebo.
In relation to the TD task, administration of dexamphetamine induced a leftwards shift in both the point of subjective equality (bias to report comparison intervals to be "longer" than the standard interval) and the vertex of the response times to the trials. Neither of these effects was associated with working memory capacity.
In the placebo condition, baseline working memory (as assessed by placebo BDS scores) affected performance on the RTE and PTP tasks. Participants with larger working memory capacity judged the duration of elapsed intervals on the RTE task to be shorter, and produced longer intervals on the PTP task, than participants with lower working capacity. This relationship was reversed after dexamphetamine administration; increasing placebo BDS scores were associated with an overestimation and underproduction of intervals.
The precision of temporal processing, as assessed by the Weber fraction, did not differ significantly between placebo and dexamphetamine conditions on any of the tasks. No evidence of a dexamphetamine-induced increase in pleasantness ratings of pictures was found. These findings will now be discussed in turn.
Dopaminergic regulation of the internal pacemaker for hundreds-to-thousands of milliseconds intervals (TD task)
The current study found a concurrent leftward shift in the point of subjective equality and response times on a task assessing temporal discrimination of intervals in the hundreds-to-thousands of milliseconds range in the dexamphetamine condition, with no association with working memory scores. In this task, participants were required to judge whether a comparison interval had the same or different length than a standard interval. The tendency for participants to perceive intervals to be "longer" than standard intervals is consistent with an increase in the speed of an internal pacemaker and a faster accumulation of temporal units in an interval.
This finding is also consistent with our hypothesis, and with studies involving the administration of indirect dopamine agonists (such as dexamphetamine or cocaine) or dopamine receptor agonists (such as pergolide) in animal studies (Cheng et al., 2006; MacDonald & Meck, 2005; Matell et al., 2006; Saulsgiver et al., 2006) and in healthy human volunteers (Lake & Meck, 2013; Rammsayer, 2009; Weiner & Ross, 1962) . This finding is also the opposite direction of performance when the rate of the internal pacemaker is reduced via the reduction of dopamine transmission (Lake & Meck, 2013; Lustig & Meck, 2005; Rammsayer, 1993 Rammsayer, , 1997 Rammsayer, , 1999 Rammsayer & Vogel, 1992 ).
An alternative explanation for the current results is that the shift in the response curve may be due to impulsive responses induced by dexamphetamine. The sigmoidal curve of long-to-short responses produced in the TD task does not appear to be globally shifted as the largest difference in response rate between drug conditions appears to be limited to the 1200-ms comparison interval. It is possible that, after administration of dexamphetamine, participants were unable to inhibit an initial response to the 1200-ms comparison interval, resulting in an increased proportion of long responses. However, the concurrent shift in both the PSE and the response times on this task is difficult to explain if impulsivity affected responses to one comparison interval. Further reasoning against this possibility is that impulsive responding would lead to an increase in the variability of the proportion of long-to-short responses across all comparison intervals if the increased impulsivity equally affected both long and short responses. As there were no significant effects of dexamphetamine on the Weber fraction, no evidence for such an increase in the variability of responses was found.
The finding that performance on the TDT was not predicted by working memory, as assessed by the BDS, contradicts previous findings that working memory is involved in the processing of intervals in the hundreds-to-thousands of milliseconds range (Fortin & Breton, 1995; Fortin et al., 1993; Rammsayer & Lima, 1991) . However, Rammsayer (1999) also found no relationship between cognitive performance and performance on a temporal discrimination task involving 1000-ms intervals after administration of haloperidol or midazolam. This discrepancy between the pharmacological studies and previous experimental studies may arise due to the different cognitive demands involved in each time-perception task. More specifically, the behavioral studies without pharmacological interventions examined the interference of non-temporal cognitive processing on performance on time-perception tasks (Fortin & Breton, 1995; Fortin et al., 1993; Rammsayer & Lima, 1991) . The increased working memory load due to the direct engagement of working memory employed in these studies would then have impacted on time perception. The current study and Rammsayer (1999) employed temporal discrimination tasks without distraction or interference. Without direct manipulation of working memory, it may be that working memory abilities of the subjects in these samples were sufficient to perform the task at this interval range, regardless of baseline working memory capacity or any pharmacologically induced changes in that capacity.
The current results have important implications for research of time perception in disorders involving altered dopamine transmission, particularly schizophrenia. The dopamine hypothesis of schizophrenia posits that dopaminergic dysregulation results in the symptoms of schizophrenia and has found support in multiple areas of research (see Howes, McCutcheon, & Stone, 2015 , for a review). More recently, functional neuroimaging has demonstrated that the specific dopaminergic dysregulation observed in schizophrenia is an increase in presynaptic dopamine production in the dorsal striatum (Kegeles et al., 2010; Kumakura et al., 2007; Lindström et al., 1999; McGowan, Lawrence, Sales, Quested, & Grasby, 2004; Reith et al., 1994) , the same region responsible for dopaminergic regulation of time perception (Matell & Meck, 2004; Meck & Benson, 2002; Meck et al., 2008) . Multiple studies have found that people with schizophrenia perceive intervals of hundredsto-thousands of milliseconds on this scale to be shorter compared to controls, indicative of decreased clock speed (Elvevåg et al., 2003 (Elvevåg et al., , 2004 Graham-Schmidt, Martin-Iverson, Holmes, & Waters, 2016; K.-H. Lee et al., 2009; Waters & Jablensky, 2009 ). Further, this study found no evidence of an increase in temporal precision, while a recent meta-analysis of studies assessing time perception in people with schizophrenia demonstrated a clear and consistent reduction in temporal precision in this disorder (Thoenes & Oberfeld, 2017) . Although the authors interpreted this decrease in precision as evidence of variability in clock speed, it is also possible that such a decrease in precision could be attributable to reduction in temporal resolution subsequent to a decrease in clock speed. As such, there appears to be a discrepancy in the current clinical and non-clinical evidence regarding the role of dopamine in schizophrenia and timing. A potential explanation for these divergent findings is that most clinical studies have investigated patients treated with antipsychotic medication. All current antipsychotic medications are competitive antagonists or partial agonists of the dopamine D 2 receptor (Horacek et al., 2006; Seeman, 2006; Seeman & Lee, 1975; Seeman, Lee, Chau-Wong, & Wong, 1976) , thereby affecting the speed of an internal pacemaker when administered. One difficulty with this explanation is that studies have not found any association between performance on time-perception tasks and chlorpromazine equivalents (Carroll, Boggs, O'Donnell, Shekhar, & Hetrick, 2008; Carroll, O'Donnell, Shekhar, & Hetrick, 2009; GrahamSchmidt et al., 2016; K.-H. Lee et al., 2009 ). Confirmation of this research question could be investigated by examining time perception in antipsychotic-naïve people with schizophrenia and others on the schizophrenia spectrum.
Dopaminergic regulation of seconds-to-minutes intervals (retrospective time estimation and prospective time production) is mediated by working memory In line with our hypothesis, the current study found that, in the placebo condition, time perception of seconds-tominutes intervals was mediated by working memory (as assessed by the backwards digit span task). Contrary to our second hypothesis that increased working memory capacity would be associated with increased retrospective estimates of intervals and decreased produced intervals, increased working memory capacity was associated with (1) shorter estimation of intervals on the RTE task, and (2) higher produced intervals on the PTP task.
Contrary to our hypothesis that the influence of working memory on time perception would no longer be present after administration of dexamphetamine, the effects of increased dopamine transmission induced by dexamphetamine were mediated by the baseline working memory capacity of participants. Analyses demonstrated that dexamphetamine administration increased BDS scores in participants with lower BDS scores in the placebo condition but had no effect on those with higher BDS scores. Further, despite the RTE and TPT tasks having different distractors, the results from both tasks in the current study were consistent. This provides an indication that the results were not spurious but do indeed reflect dexamphetamine-induced changes in time perception. No evidence of an alteration of timing precision, as assessed with the Weber fraction, was found. The finding of an association of lower working memory capacity with an increase in interval estimations in the placebo condition has precedent in the literature. A previous study investigating time perception in people with frontal lesions, and a corresponding decrease in working memory capacity, also reported an increase in retrospective time estimations of seconds-to-minutes intervals in this group, compared to healthy controls (Mimura et al., 2000) . The authors proposed that the lesion-induced reduction in working memory capacity results in a more rapid turnover of information in working memory, resulting in a faster accumulation of temporal units and an overestimation of time. Such an effect is presumably responsible for the relationship between working memory capacity and time perception seen in the current study. More specifically, increasing working memory capacity was associated with better storage of accumulated time units and lower turnover of information in working memory, leading to decrease in the estimation, and an increase in the production, of intervals in the placebo condition.
The current findings in the dexamphetamine condition are consistent with an increase in the speed of an internal pacemaker that is mediated by working memory. Specifically, an overestimation and underproduction of intervals was observed in those participants whose baseline working memory capacity was sufficient to allow the accumulation of the increased number of temporal units produced by increased dopamine transmission. Interestingly, those participants with low placebo BDS scores, and hence a relatively lower working memory capacity, were observed to underestimate and overproduce intervals in the dexamphetamine condition, relative to the placebo condition. As the secondary analysis of the BDS scores demonstrated, those participants with lower placebo BDS scores experienced an increase in working memory capacity (reflected in the improved BDS scores) after administration of dexamphetamine. An improvement in working memory in participants with low baseline capacity has been observed previously in other studies that have administered indirect dopamine agonists to healthy controls (Luciana, Depue, Arbisi, & Leon, 1992; Mattay et al., 2000; Mehta et al., 2000) . Presumably, the increased working memory capacity in the dexamphetamine condition was then associated with a slower turnover of information in working memory, a slower accumulation of temporal units, a reduction in the estimation of elapsed intervals, and an increase in the production of intervals by people with low placebo BDS scores. Alternatively, low basal dopamine levels are associated with global reductions in executive function (Cools & D'Esposito, 2011; Goldman-Rakic, 1997; Goto et al., 2007; Mattay et al., 2000; Vijayraghavan et al., 2007) . Administration of dexamphetamine may have improved executive functions other than working memory, particularly attention, in people with low placebo BDS scores. Improved attention in these people would result in improved allocation of cognitive resources to the time-perception task and an improved maintenance of task-relevant information. This in turn would result in improved accumulation of temporal units and the relative overestimation and underproduction of intervals observed in the dexamphetamine condition.
Although the current study and Lake and Meck (2013) found that the effects of dexamphetamine on time perception were mediated by working memory and attention, respectively, opposite effects were found for participant with high and low cognitive performance. The current study only found changes in time perception consistent with increased clock speed in people with high cognitive performance (high placebo BDS scores). In contrast, Lake and Meck reported that changes in time perception consistent with increased clock speed were only present in subjects with low cognitive performance (high rate of attentional lapses) and who reported low enjoyment of the psychological effects of dexamphetamine. Conversely, subjects with high cognitive performance (low rate of attentional lapses) and who reported enjoyment of dexamphetamine intoxication demonstrated overproduction of 7-s and 17-s intervals. These authors speculated that the euphoric drug effects increased distractibility and decreased attentional resources dedicated to the time-perception task in this subgroup (Lake & Meck, 2013) . The current study and that of Lake and Meck provide further evidence for the importance of baseline cognitive performance in the time perception of seconds-to-minutes intervals. Further, both studies suggest that the effects of increased dopamine transmission on time perception of these intervals are mediated by executive function. However, the current study did not assess attention and did not have an effective measure of how much participants liked the drug; furthermore, a measure of working memory was not reported by Lake and Meck (2013) . For this reason, the cause for the divergent findings between the studies is not clear. It may be that the RTE and PTP tasks differentially engage attention and working memory, in comparison to the peak interval procedure. The effects of dexamphetamine on time perception are then dependent upon which cognitive function is more prominently involved in each task. Alternatively, the samples used in each study may have differed in their baseline cognitive performance, a possibility given the large range of BDS scores in the current study (3-12 of a possible range of 0-15). The relative contribution of alterations of attention and working memory on time perception due to increased dopamine transmission is an area that should be addressed by future studies.
The current findings again have important implications for other disorders that are associated with altered dopaminergic transmission. People with schizophrenia tend to overestimate intervals in the seconds-to-minutes range, a finding interpreted as an increase in the speed of the internal pacemaker (Densen, 1977; Johnson & Petzel, 1971; Tracy et al., 1998; Tysk, 1983a Tysk, , 1983b Tysk, , 1990 Wahl & Sieg, 1980) . Both increased pacemaker speed and higher turnover of information in working memory lead to the same behavior, that is, an overestimation of elapsed intervals and reduced prospective production of intervals. However, the findings of the current study and previous findings of an association of working memory with time perception impairments in people with schizophrenia (GrahamSchmidt et al., 2016; K.-H. Lee et al., 2009; Roy et al., 2012) indicate that the alterations of time perception of seconds-to-minutes intervals in people with schizophrenia are primarily influenced by working memory. The consistent findings of impaired working memory related to underactivation of the prefrontal cortex in people with schizophrenia lends further credence to this hypothesis (Glahn et al., 2003; Hartman, Steketee, Silva, Lanning, & McCann, 2003; J. Lee & Park, 2005; Menon, Anagnoson, Mathalon, Glover, & Pfefferbaum, 2001; Tek et al., 2002) .
Limitations
The participants in this study did not report or display any psychosis-or schizophrenia-like symptoms after administration of dexamphetamine, nor did we directly measure these behavioral changes. As such, we were unable to demonstrate that the observed changes in time perception were correlated with an increase in psychosis-like symptoms. Further research in this area should examine this link explicitly.
The measure used to assess changes in dexamphetamineinduced euphoria, the rating of pictures from the International Affective Picture System, did not reveal any significant effects of dexamphetamine administration. However, other studies with smaller doses of dexamphetamine and more direct measures of dexamphetamine-induced euphoria have found significant changes in ratings of euphoria after dexamphetamine administration (Drevets et al., 2001; McCloskey, Palmer, & de Wit, 2010) . It is therefore likely that the measure used in the current study was not sensitive enough to detect such changes and it cannot be discounted that such effects are present in the current study.
Finally, dexamphetamine also causes significant increases in synaptic levels of noradrenaline (Kuczenski & Segal, 1997; Sulzer, Sonders, Poulsen, & Galli, 2005) and, to a lesser extent, serotonin (Rothman et al., 2001) . Given both neurotransmitters have been implicated in executive functions, such as attention and working memory, and time perception, it is possible that some of the effects observed in the current study are due to manipulation of these monoaminergic pathways.
Conclusions
Administration of 0.45 mg/kg dexamphetamine to healthy volunteers produced an increase in the perceived length of intervals in a time-discrimination task of hundreds-tothousands of milliseconds intervals. This finding is consistent with an increase in the speed of an internal pacemaker caused by increased synaptic levels of dopamine. No effects of dexamphetamine on temporal precision were found in this interval range. The effects of dexamphetamine administration on the perception of intervals in the seconds-to-minutes range were mediated by the baseline working memory capacity of the subjects, and did not affect the precision of temporal judgments. Higher backwards digit span scores in the placebo condition, and thus higher working memory capacity, were associated with an overestimation and underproduction of intervals in the dexamphetamine condition. This result is also consistent with an increase in the speed of an internal pacemaker. However, lower backwards digit span scores in the placebo condition, and thus lower working memory capacity, were associated with an underestimation and overproduction of intervals in the dexamphetamine condition. Dexamphetamine administration increased the working memory capacity of those participants with lower baseline backwards digit span scores, possibly leading to a reduction in the turnover of information in working memory and a subsequent alteration in time perception. These results confirm the importance of dopaminergic regulation of time perception in the hundreds-tothousands of milliseconds and seconds-to-minutes interval ranges, as well as the importance of cognitive mediation of time perception for the latter range of intervals.
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